Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enervon is an over-the-counter (OTC) multivitamin and wellness supplement developed and marketed by United International Pharma, a member of the Unilab Group. The product is formulated as a film-coated tablet specifically containing a high dose of Vitamin C (500mg) in combination with a Vitamin B-complex, including Vitamin B1 (thiamine), B2 (riboflavin), B3 (niacinamide), B5 (calcium pantothenate), B6 (pyridoxine), and B12 (cyanocobalamin). It is indicated for nutritional supplementation to treat or prevent deficiencies of Vitamin C and B-complex vitamins, particularly during periods of increased physical and mental exertion, fatigue, or rapid growth in adolescents and adults. As a nutritional supplement, it functions by providing essential cofactors for various metabolic processes rather than targeting a single pharmaceutical receptor. The product is manufactured in an EU-GMP certified facility in Vietnam and is a prominent consumer healthcare brand in the Southeast Asian market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Enervon.